BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10514505)

  • 1. CrkL mediates Ras-dependent activation of the Raf/ERK pathway through the guanine nucleotide exchange factor C3G in hematopoietic cells stimulated with erythropoietin or interleukin-3.
    Nosaka Y; Arai A; Miyasaka N; Miura O
    J Biol Chem; 1999 Oct; 274(42):30154-62. PubMed ID: 10514505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rac is activated by erythropoietin or interleukin-3 and is involved in activation of the Erk signaling pathway.
    Arai A; Kanda E; Miura O
    Oncogene; 2002 Apr; 21(17):2641-51. PubMed ID: 11965537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin and IL-3 induce tyrosine phosphorylation of CrkL and its association with Shc, SHP-2, and Cbl in hematopoietic cells.
    Chin H; Saito T; Arai A; Yamamoto K; Kamiyama R; Miyasaka N; Miura O
    Biochem Biophys Res Commun; 1997 Oct; 239(2):412-7. PubMed ID: 9344843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CrkL is recruited through its SH2 domain to the erythropoietin receptor and plays a role in Lyn-mediated receptor signaling.
    Arai A; Kanda E; Nosaka Y; Miyasaka N; Miura O
    J Biol Chem; 2001 Aug; 276(35):33282-90. PubMed ID: 11443118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CrkL activates integrin-mediated hematopoietic cell adhesion through the guanine nucleotide exchange factor C3G.
    Arai A; Nosaka Y; Kohsaka H; Miyasaka N; Miura O
    Blood; 1999 Jun; 93(11):3713-22. PubMed ID: 10339478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CrkL plays a role in SDF-1-induced activation of the Raf-1/MEK/Erk pathway through Ras and Rac to mediate chemotactic signaling in hematopoietic cells.
    Arai A; Aoki M; Weihua Y; Jin A; Miura O
    Cell Signal; 2006 Dec; 18(12):2162-71. PubMed ID: 16781119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rap1 is activated by erythropoietin or interleukin-3 and is involved in regulation of beta1 integrin-mediated hematopoietic cell adhesion.
    Arai A; Nosaka Y; Kanda E; Yamamoto K; Miyasaka N; Miura O
    J Biol Chem; 2001 Mar; 276(13):10453-62. PubMed ID: 11124936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of guanine-nucleotide exchange activity of C3G for Rap1 by the expression of Crk, CrkL, and Grb2.
    Ichiba T; Kuraishi Y; Sakai O; Nagata S; Groffen J; Kurata T; Hattori S; Matsuda M
    J Biol Chem; 1997 Aug; 272(35):22215-20. PubMed ID: 9268367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adapter protein Crkl links Cbl to C3G after integrin ligation and enhances cell migration.
    Uemura N; Griffin JD
    J Biol Chem; 1999 Dec; 274(53):37525-32. PubMed ID: 10608804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin and interleukin-3 activate tyrosine phosphorylation of CBL and association with CRK adaptor proteins.
    Barber DL; Mason JM; Fukazawa T; Reedquist KA; Druker BJ; Band H; D'Andrea AD
    Blood; 1997 May; 89(9):3166-74. PubMed ID: 9129019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Crk signaling pathway contributes to the bombesin-induced activation of the small GTPase Rap1 in Swiss 3T3 cells.
    Posern G; Rapp UR; Feller SM
    Oncogene; 2000 Dec; 19(54):6361-8. PubMed ID: 11175351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential interaction of Crkl with Cbl or C3G, Hef-1, and gamma subunit immunoreceptor tyrosine-based activation motif in signaling of myeloid high affinity Fc receptor for IgG (Fc gamma RI).
    Kyono WT; de Jong R; Park RK; Liu Y; Heisterkamp N; Groffen J; Durden DL
    J Immunol; 1998 Nov; 161(10):5555-63. PubMed ID: 9820532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin induces association of Crkl with STAT5 but not STAT3 in human platelets.
    Ozaki K; Oda A; Wakao H; Rhodes J; Druker BJ; Ishida A; Wakui M; Okamoto S; Morita K; Handa M; Komatsu N; Ohashi H; Miyajima A; Ikeda Y
    Blood; 1998 Dec; 92(12):4652-62. PubMed ID: 9845531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CrkL adapter protein is required for type I interferon-dependent gene transcription and activation of the small G-protein Rap1.
    Lekmine F; Sassano A; Uddin S; Majchrzak B; Miura O; Druker BJ; Fish EN; Imamoto A; Platanias LC
    Biochem Biophys Res Commun; 2002 Mar; 291(4):744-50. PubMed ID: 11866427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crk proteins activate the Rap1 guanine nucleotide exchange factor C3G by segregated adaptor-dependent and -independent mechanisms.
    Rodríguez-Blázquez A; Carabias A; Morán-Vaquero A; de Cima S; Luque-Ortega JR; Alfonso C; Schuck P; Manso JA; Macedo-Ribeiro S; Guerrero C; de Pereda JM
    Cell Commun Signal; 2023 Feb; 21(1):30. PubMed ID: 36737758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proto-oncogene products Vav and c-Cbl are involved in the signal transduction through Grb2/Ash in hematopoietic cells.
    Hanazono Y; Odai H; Sasaki K; Iwamatsu A; Yazaki Y; Hirai H
    Acta Haematol; 1996; 95(3-4):236-42. PubMed ID: 8677749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The signal transduction through Grb2/Ash in hematopoietic cells.
    Odai H; Hanazono Y; Sasaki K; Iwamatu A; Yazaki Y; Hirai H
    Leukemia; 1997 Apr; 11 Suppl 3():405-7. PubMed ID: 9209406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of Bcr/Abl with C3G, an exchange factor for the small GTPase Rap1, through the adapter protein Crkl.
    Cho YJ; Hemmeryckx B; Groffen J; Heisterkamp N
    Biochem Biophys Res Commun; 2005 Aug; 333(4):1276-83. PubMed ID: 15982636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-gamma activates the C3G/Rap1 signaling pathway.
    Alsayed Y; Uddin S; Ahmad S; Majchrzak B; Druker BJ; Fish EN; Platanias LC
    J Immunol; 2000 Feb; 164(4):1800-6. PubMed ID: 10657627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.